CELLULAR BIOMEDICINE GROUP I's ticker is and the CUSIP is 15117P902. A total of 1 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $0 | – | 101 | -8.2% | 0.00% | – |
| Q3 2020 | $0 | – | 110 | +10900.0% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 1 | -95.0% | 0.00% | – |
| Q1 2020 | $31,000 | -16.2% | 20 | -13.0% | 0.00% | – |
| Q4 2019 | $37,000 | +3600.0% | 23 | +2200.0% | 0.00% | – |
| Q3 2018 | $1,000 | -95.2% | 1 | -90.9% | 0.00% | – |
| Q2 2018 | $21,000 | – | 11 | +1000.0% | 0.00% | – |
| Q1 2018 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 11 | $21,000 | 0.00% |